Evidence map›Paper›PMID 39110504›Full record

ArticleJMIR research protocols2024

Engagement With Conversational Agent-Enabled Interventions in Cardiometabolic Disease Management: Protocol for a Systematic Review.

Nick Kashyap, Ann Tresa Sebastian, Chris Lynch, Paul Jansons, Ralph Maddison, Tilman Dingler, Brian Oldenburg

Abstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nick KashyapBaker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Australia.ORCID 0009-0008-6577-2454
Ann Tresa SebastianCentre for Research Excellence in Digital Technology to Transform Chronic Disease Outcomes, National Health and Medical Research Council, Melbourne, Australia.ORCID 0000-0002-9291-4525
Chris LynchBaker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Australia.ORCID 0000-0001-9503-6994
Paul JansonsCentre for Research Excellence in Digital Technology to Transform Chronic Disease Outcomes, National Health and Medical Research Council, Melbourne, Australia.ORCID 0000-0002-8766-0516
Ralph MaddisonCentre for Research Excellence in Digital Technology to Transform Chronic Disease Outcomes, National Health and Medical Research Council, Melbourne, Australia.ORCID 0000-0001-8564-5518
Tilman DinglerCentre for Research Excellence in Digital Technology to Transform Chronic Disease Outcomes, National Health and Medical Research Council, Melbourne, Australia.ORCID 0000-0001-6180-7033
Brian OldenburgBaker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Australia.ORCID 0000-0002-7712-5413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiometabolic diseases (CMDs) are a group of interrelated conditions, including heart failure and diabetes, that increase the risk of cardiovascular and metabolic complications. The rising number of Australians with CMDs has necessitated new strategies for those managing these conditions, such as digital health interventions. The effectiveness of digital health interventions in supporting people with CMDs is dependent on the extent to which users engage with the tools. Augmenting digital health interventions with conversational agents, technologies that interact with people using natural language, may enhance engagement because of their human-like attributes. To date, no systematic review has compiled evidence on how design features influence the engagement of conversational agent-enabled interventions supporting people with CMDs. This review seeks to address this gap, thereby guiding developers in creating more engaging and effective tools for CMD management.

objectiveThe aim of this systematic review is to synthesize evidence pertaining to conversational agent-enabled intervention design features and their impacts on the engagement of people managing CMD.

methodsThe review is conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and reported in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Searches will be conducted in the Ovid (Medline), Web of Science, and Scopus databases, which will be run again prior to manuscript submission. Inclusion criteria will consist of primary research studies reporting on conversational agent-enabled interventions, including measures of engagement, in adults with CMD. Data extraction will seek to capture the perspectives of people with CMD on the use of conversational agent-enabled interventions. Joanna Briggs Institute critical appraisal tools will be used to evaluate the overall quality of evidence collected.

resultsThis review was initiated in May 2023 and was registered with the International Prospective Register of Systematic Reviews (PROSPERO) in June 2023, prior to title and abstract screening. Full-text screening of articles was completed in July 2023 and data extraction began August 2023. Final searches were conducted in April 2024 prior to finalizing the review and the manuscript was submitted for peer review in July 2024.

conclusionsThis review will synthesize diverse observations pertaining to conversational agent-enabled intervention design features and their impacts on engagement among people with CMDs. These observations can be used to guide the development of more engaging conversational agent-enabled interventions, thereby increasing the likelihood of regular intervention use and improved CMD health outcomes. Additionally, this review will identify gaps in the literature in terms of how engagement is reported, thereby highlighting areas for future exploration and supporting researchers in advancing the understanding of conversational agent-enabled interventions.

trial registrationPROSPERO CRD42023431579; https://tinyurl.com/55cxkm26. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/52973.

Indexed as

Cardiovascular DiseasesSystematic Reviews as TopicAustraliaCommunicationDisease ManagementHumansMetabolic DiseasesacceptabilityadultAustraliacardiometabolic diseasecardiovascular diseasechatbotchronic diseaseconversational agent–enableddesigndiabetesdigital healthdigital health interventionhealth informaticsheart failuremanagementmeta-analysisnatural language processingsystematic reviewtechnology acceptance model

Identifiers

PMID39110504
PMCPMC11339562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.